Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,392 | 5 | 76.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600.00 | 2 | 19.1% |
| Food and Beverage | $142.96 | 1 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $2,992 | 7 | $0 (2020) |
| Abbott Laboratories | $142.96 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $142.96 | 1 | Abbott Laboratories ($142.96) |
| 2020 | $508.33 | 1 | Becton, Dickinson and Company ($508.33) |
| 2019 | $1,092 | 3 | Becton, Dickinson and Company ($1,092) |
| 2018 | $1,392 | 3 | Becton, Dickinson and Company ($1,392) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $142.96 | General |
| Category: Heart Failure | ||||||
| 10/01/2020 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $508.33 | General |
| 11/19/2019 | Becton, Dickinson and Company | CFN MEDMINED (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: MEDICAL SYSTEMS | ||||||
| 10/18/2019 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $491.67 | General |
| 10/10/2019 | Becton, Dickinson and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| 08/30/2018 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $416.67 | General |
| 04/26/2018 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 04/12/2018 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 353 | 918 | $411,535 | $85,768 |
| 2022 | 12 | 476 | 1,056 | $431,041 | $90,740 |
| 2021 | 8 | 415 | 1,217 | $447,772 | $97,325 |
| 2020 | 8 | 316 | 852 | $308,579 | $66,713 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 118 | 447 | $143,934 | $32,337 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 248 | $114,080 | $27,092 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 99 | $68,211 | $10,143 | 14.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 63 | $55,377 | $10,050 | 18.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 47 | $28,435 | $5,643 | 19.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $1,498 | $503.72 | 33.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 167 | 655 | $210,910 | $43,967 | 20.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 61 | $53,619 | $11,392 | 21.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 54 | 110 | $50,600 | $10,565 | 20.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 60 | $36,300 | $7,735 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 50 | $34,450 | $5,751 | 16.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $9,540 | $3,337 | 35.0% |
| 90739 | Hepatitis b vaccine, adult dosage | Office | 2022 | 14 | 18 | $7,794 | $2,621 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $10,087 | $1,790 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $11,856 | $1,631 | 13.8% |
| G0010 | Administration of hepatitis b vaccine | Office | 2022 | 15 | 19 | $2,033 | $674.47 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $2,033 | $671.23 | 33.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $1,819 | $604.61 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 168 | 897 | $288,834 | $63,202 | 21.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 91 | 105 | $63,525 | $13,955 | 22.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 35 | $30,765 | $6,736 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 57 | $21,831 | $4,646 | 21.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 37 | $17,020 | $3,711 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 25 | $11,875 | $2,844 | 24.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 20 | $7,660 | $977.70 | 12.8% |
About Dr. Frances Wallach, MD
Dr. Frances Wallach, MD is a Infectious Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255360087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frances Wallach, MD has received a total of $3,135 in payments from pharmaceutical and medical device companies, with $142.96 received in 2023. These payments were reported across 8 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($2,392).
As a Medicare-enrolled provider, Wallach has provided services to 1,560 Medicare beneficiaries, totaling 4,043 services with total Medicare billing of $340,546. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location New York, NY
- Active Since 07/02/2006
- Last Updated 12/06/2010
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255360087
Products in Payments
- CFN MEDMINED (Device) $300.00
- CARDIOMEMS (Device) $142.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in New York
Sian Jones, Md, MD
Infectious Disease — Payments: $349,236
Dr. David Bekhor, Md, MD
Infectious Disease — Payments: $309,279
Genovefa Papanicolaou, Md, MD
Infectious Disease — Payments: $183,179
Dr. Michelle Cespedes, M.d, M.D
Infectious Disease — Payments: $136,443
Mr. Jose Cortes, M.d, M.D
Infectious Disease — Payments: $123,792
Dr. Martin Markowitz, Md, MD
Infectious Disease — Payments: $112,821